Following a high-profile launch event at the Mandrake Hotel in central London and a notable presence at the inaugural Europe CBD Expo, Ignite International Brands (U.K), Ltd. (CSE:BLIZ) (“Ignite UK”) has now officially launched the Ignite brand of products in Europe via the United Kingdom.

Ignite UK enters the European market with an exciting line up of lifestyle-based CBD products that include drops (tinctures), vapes and topicals. These products are 100% natural and dosed to provide effects of calm, lucid and recharge. As your day changes, so should your CBD.

Ignite UK has released five (5) drop flavours and three (3) vape flavours, with additional SKUs scheduled for release in the near term. New to the Ignite line-up is a CBD Lip Balm, which serves as a reasonably-priced entry point for the consumer curious about Ignite and/or CBD topicals.

Ignite UK sources the purest full spectrum distillate and 99% pure CBD isolate and infuses them with fractionated coconut oil, natural flavour extracts and terpenes, all of which are formulated to provide the exhilarating, clarifying benefits of CBD.

European consumers can now purchase Ignite CBD Drops, Disposable Vape Pens and Lip Balms at two London retail locations as well as online at

Jim McCormick, President of Ignite International Brands, Ltd. (“Ignite”), the parent company of Ignite UK, adds: “North American CBD companies are increasing their presence in the UK and Europe to enter a market that is anticipated to reach £16.5 billion in the next decade. We are excited to have launched our Ignite CBD product line in Europe. The initial response has been tremendous, and we look forward to diversifying our business across the UK and EU member states with our trade partners in the UK.”

As part of a large-scale media activation, London will be graced with the “Ignited Kingdom” marketing campaign. Strategically placed digital screens and billboards will demonstrate the balanced, aspirational lifestyle Ignite UK encourages through CBD use.

CBD is still relatively new in the UK and Europe. Although there have been a number of campaigns to date, none have been on a significant scale nor has a dominant brand yet to emerge. Ignite UK intends to capitalize on this opportunity with its first mover advantage and already massive social media reach. With the integration of traditional and digital out-of-home marketing combined with social influencer campaigns, Ignite UK aims to become the most recognizable CBD brand in the EU.


Ignite is a CSE-listed company operating in the CBD industry. Ignite intends to expand its business, which currently includes branding, marketing, licensing, sales and distribution, across the United States, Canada and international jurisdictions, and leverage multiple product platforms. Ignite intends to effect this expansion through brand leverage, product development, targeted marketing and strategic supply chain partnerships in each of the target jurisdictions.  As CEO and Chairman, Dan Bilzerian takes an active role and is deeply involved in the development of global strategic initiatives intended to establish Ignite as a global leader in the CBD space.


This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the CBD market in Europe, the diversification of Ignite’s business and the business and marketing strategies of Ignite and Ignite UK. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; ability of Ignite and Ignite UK to give effect to their business plans; reliance on Dan Bilzerian and the “IGNITE” brand which may not prove to be as successful as contemplated; the ability to and risks associated with unlocking future licensing opportunities with the “IGNITE” brand, building a global CBD brand and the ability of Ignite and Ignite UK to capture significant market share; ability to source and secure companies or businesses to acquire and risks related to the acquisition of such companies or businesses; and the uncertainties surrounding the CBD industry in North America and internationally. There can be no assurance that any of the forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Ignite and Ignite UK disclaim any intention or obligation to update or revise any forward-looking statements, whether because of new information, future events or otherwise, except as required by law.

Click here to connect with Ignite International Brands (CSE:BILZ) for an Investor Presentation


  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less